Kosuke Iwatani

671 total citations
57 papers, 275 citations indexed

About

Kosuke Iwatani is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Kosuke Iwatani has authored 57 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 30 papers in Surgery and 9 papers in Oncology. Recurrent topics in Kosuke Iwatani's work include Bladder and Urothelial Cancer Treatments (27 papers), Prostate Cancer Treatment and Research (22 papers) and Prostate Cancer Diagnosis and Treatment (17 papers). Kosuke Iwatani is often cited by papers focused on Bladder and Urothelial Cancer Treatments (27 papers), Prostate Cancer Treatment and Research (22 papers) and Prostate Cancer Diagnosis and Treatment (17 papers). Kosuke Iwatani collaborates with scholars based in Japan, United States and Jordan. Kosuke Iwatani's co-authors include Takahiro Kimura, Shin Egawa, Jun Miki, Takafumi Yanagisawa, Shun Sato, Hiroyuki Takahashi, Fumihiko Urabe, Shunsuke Tsuzuki, Kojiro Tashiro and Shoji Kimura and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Kosuke Iwatani

46 papers receiving 275 citations

Peers

Kosuke Iwatani
C. Surcel Romania
Nicolas Branger France
Kelly E. Maloney United States
François‐Xavier Nouhaud France
P Øgreid Norway
Jonathan Olivier France
Mary Achim United States
Sacha Wolf United States
Marguerite du Plessis United States
Laurence Bastien France
C. Surcel Romania
Kosuke Iwatani
Citations per year, relative to Kosuke Iwatani Kosuke Iwatani (= 1×) peers C. Surcel

Countries citing papers authored by Kosuke Iwatani

Since Specialization
Citations

This map shows the geographic impact of Kosuke Iwatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Iwatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Iwatani more than expected).

Fields of papers citing papers by Kosuke Iwatani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Iwatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Iwatani. The network helps show where Kosuke Iwatani may publish in the future.

Co-authorship network of co-authors of Kosuke Iwatani

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Iwatani. A scholar is included among the top collaborators of Kosuke Iwatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Iwatani. Kosuke Iwatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwatani, Kosuke, Fumihiko Urabe, Masataka Kubo, et al.. (2025). Initial Experience of Robot‐Assisted Nephrectomy and Nephroureterectomy Using the Novel Saroa Surgical System. International Journal of Urology. 32(10). 1464–1471.
2.
Yanagisawa, Takafumi, Wataru Fukuokaya, Shingo Hatakeyama, et al.. (2024). Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study. The Prostate. 85(2). 165–174. 4 indexed citations
3.
Urabe, Fumihiko, Takafumi Yanagisawa, Wataru Fukuokaya, et al.. (2024). Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study. International Journal of Urology. 31(11). 1248–1255. 3 indexed citations
4.
Urabe, Fumihiko, Wataru Fukuokaya, Kosuke Iwatani, et al.. (2024). Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study. Clinical Genitourinary Cancer. 22(3). 102082–102082.
5.
Iwatani, Kosuke, et al.. (2024). Initial experience of a novel surgical assist robot “Saroa” featuring tactile feedback and a roll-clutch system in radical prostatectomy. Scientific Reports. 14(1). 31727–31727. 3 indexed citations
6.
7.
Sasaki, Hiroshi, Yusuke Takahashi, Kosuke Iwatani, et al.. (2024). Effectiveness of Magnetic Resonance Imaging/Ultrasound-guided Target Biopsy in Detecting Clinically Significant Prostate Cancer. Anticancer Research. 44(2). 679–686.
8.
Yanagisawa, Takafumi, Wataru Fukuokaya, Kosuke Iwatani, et al.. (2023). Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis. Urologic Oncology Seminars and Original Investigations. 41(3). 150.e11–150.e19. 7 indexed citations
9.
Urabe, Fumihiko, Hirotaka Suzuki, Wataru Fukuokaya, et al.. (2023). The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study. International Journal of Urology. 31(4). 394–401.
10.
Iwatani, Kosuke, Jun Miki, Fumihiko Urabe, et al.. (2023). Effectiveness of everolimus for sporadic renal angiomyolipoma with inferior vena cava thrombus: A case report. Urology Case Reports. 50. 102520–102520. 1 indexed citations
11.
Urabe, Fumihiko, Wataru Fukuokaya, Kosuke Iwatani, et al.. (2023). Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study. International Journal of Urology. 31(2). 125–132. 4 indexed citations
12.
Urabe, Fumihiko, Kenta Miki, Hirotaka Suzuki, et al.. (2023). Effect of Adequate Local Radiation Dose on Oncological Outcomes in Localized Prostate Cancer Patients Treated With Low-dose-rate Brachytherapy. Anticancer Research. 43(7). 3159–3166. 1 indexed citations
13.
14.
Urabe, Fumihiko, Kosuke Iwatani, Kojiro Tashiro, et al.. (2023). Patients with PSA below 0.2 ng/mL at 8 years post high‐dose‐rate brachytherapy have an extremely low risk of subsequent recurrence. International Journal of Urology. 30(12). 1147–1154.
15.
16.
Yanagisawa, Takafumi, Akihiro Matsukawa, Kosuke Iwatani, et al.. (2023). En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis. Annals of Surgical Oncology. 30(6). 3820–3828. 7 indexed citations
17.
Fukuokaya, Wataru, Takafumi Yanagisawa, Masaki Hashimoto, et al.. (2022). Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma. Cancer Immunology Immunotherapy. 72(4). 841–849. 4 indexed citations
18.
Fukuokaya, Wataru, Takahiro Kimura, Kazumasa Komura, et al.. (2022). Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors. Urologic Oncology Seminars and Original Investigations. 40(7). 346.e1–346.e8. 18 indexed citations
19.
Urabe, Fumihiko, Kosuke Iwatani, Masatoshi Tanaka, et al.. (2021). Knotted ureteral single‐J stent in a patient with ureterocutaneostomy. IJU Case Reports. 4(6). 382–385. 1 indexed citations
20.
Mori, Keiichiro, Takahiro Kimura, Wataru Fukuokaya, et al.. (2019). Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer. International Journal of Clinical Oncology. 25(3). 479–485. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Surcel Breakdown of academic impact, for papers by Nicolas Branger Breakdown of academic impact, for papers by Kelly E. Maloney Breakdown of academic impact, for papers by François‐Xavier Nouhaud Breakdown of academic impact, for papers by P Øgreid Breakdown of academic impact, for papers by Jonathan Olivier Breakdown of academic impact, for papers by Mary Achim Breakdown of academic impact, for papers by Sacha Wolf Breakdown of academic impact, for papers by Marguerite du Plessis Breakdown of academic impact, for papers by Laurence Bastien
Rankless by CCL
2026